Episode Details

Shadd Dales and co-host Anthony Varrell welcome Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX: NLCP), to respond to one of the most provocative interviews we’ve aired to date — featuring former hedge fund manager and institutional investor Marc Cohodes.Earlier this week, Cohodes delivered an unfiltered, high-conviction case for why federal cannabis reform is coming — and fast. He made bold claims: the U.S. government is finally serious about cracking down on the illicit market, and the DEA, DHS, and Treasury are laying the groundwork for cannabis policy shifts that could include safe banking, rescheduling, and even nationwide taxation under a second Trump administration.But is it all hype? Or is there real momentum building?As the head of a major U.S. cannabis REIT, Anthony Coniglio offers a grounded, data-backed view of the situation. In this episode, he reacts to Cohodes’ commentary on: • The growing enforcement pressure on illegal grows • The merging narrative around hemp and cannabis as one regulated product • Whether the illicit-to-legal transition is finally happening • The need for U.S. cannabis companies to trade on U.S. exchanges • And what federal policy reform could mean for investors, operators, and capital markets.Plus, we dig into NewLake’s strategy in this unpredictable policy environment — and why Coniglio believes this industry is still worth betting on long-term.Also joining us is Christian Angermayer, Chairman of ATAI Life Sciences (NASDAQ: ATAI), following the company’s July 1 announcement of a $50 million private placement funding round. Angermayer breaks down how the capital will advance ATAI’s clinical-stage psychedelic therapeutics — including COMPASS Pathways’ Phase 3 trial in treatment-resistant depression and Beckley Psytech’s Phase 2b 5-MeO-DMT study.He also shares insights on the future of the psychedelics industry, regulatory tailwinds, and where investor attention should be focused as the mental health treatment landscape rapidly evolves.Subscribe for a front-row seat to cannabis reform, psychedelic breakthroughs, and market-moving interviews.#CannabisIndustry #CannabisStocks #CannabisReform #SAFERBanking #Trump #TrumpAdministration #CannabisRescheduling #SafeBankingAct #PsychedelicStocks #MentalHealth #BiotechStocksWant to see last week's recap?   • The Week’s Biggest Cannabis Headlines – Fr...  Want to see more Cannabis Reform videos?   • Mike Tyson, Kevin Durant, Urge Trump to Ac...     • California Cannabis Sales Are Falling — He...     • Is Pennsylvania the Next Big Cannabis Mark...     • Texas Vetoes Hemp Ban: Here’s What It Mean...     • Alcohol Sales Are Dropping — Cannabis May ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!

Listen Now